University Of Maryland, Baltimore
Clinical trials sponsored by University Of Maryland, Baltimore, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a gut hormone protect your blood vessels during low blood sugar? Results expected Sep 2026 (estimated)
- Low blood Sugar's hidden impact on blood vessels revealed Results expected Sep 2026 (estimated)
- Scientists probe discarded tissue to unlock secrets of rare airway scarring Results expected Sep 2026 (estimated)
- Could prozac or DHEA protect against dangerous low blood sugar in diabetes? Results expected Sep 2026 (estimated)
- Shock and shake: new combo therapy aims to rebuild muscle after brain bleed Results expected Sep 2026 (estimated)
-
Massive malawi trial aims to shield kids from typhoid
Vaccine OngoingThis large phase 3 trial is testing a typhoid conjugate vaccine (Vi-TCV) in 30,000 healthy children aged 9 months to 12 years in Malawi. Half get the typhoid vaccine, half get a meningitis vaccine for comparison. The goal is to see if the typhoid vaccine prevents blood-confirmed …
Phase 3 • Sponsor: University of Maryland, Baltimore • Aim: Vaccine
Last updated Sep 19, 2026 00:00 UTC
-
Triple threat: new vaccine aims to tackle three salmonella strains at once
Vaccine OngoingThis study tests a new vaccine designed to protect against three common types of Salmonella bacteria that cause serious infections in Sub-Saharan Africa. The trial includes healthy participants ranging from adults down to young infants, and compares the vaccine to a placebo to se…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Vaccine
Last updated Jul 01, 2026 00:00 UTC
-
Triple-Target CAR T-Cells take on tough lymphomas
Disease control By invitation onlyThis early-phase trial is testing a new type of immunotherapy called tri-specific CAR T-cells that target three proteins (CD19, CD20, CD22) on cancer cells. It is for adults with B-cell lymphomas that have come back or not responded to standard treatments. The study will enroll 1…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Triple therapy tackles tough lung cancer
Disease control PausedThis early-stage trial tests the safety of combining precise radiation (SBRT) with immunotherapy (durvalumab) and two chemotherapy drugs (platinum and etoposide) for people with extensive-stage small cell lung cancer that has stopped responding to platinum chemo. The study aims t…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 16, 2026 00:00 UTC
-
Chilling the body to save the lungs: new trial for ARDS
Disease control OngoingThis study tests whether gently cooling the body (to 34-35°C) combined with muscle-paralyzing drugs can help people with severe lung injury (ARDS) recover. About 340 adults on ventilators will be randomly assigned to cooling plus paralytics or usual care. The main goal is to see …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 11, 2026 00:00 UTC
-
A wearable ankle robot may boost walking recovery after stroke
Disease control By invitation onlyThis pilot trial tests whether training with a portable robotic ankle exoskeleton, called AMBLE, can improve ankle push-off and walking speed in adults with chronic stroke and ankle weakness. Participants will complete 30 walking training sessions over 8 to 9 weeks while wearing …
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Can a dissolvable bone wax curb bleeding during spine fusion?
Disease control By invitation onlyThis study tests whether Ostene, a water-soluble material that plugs bleeding bone, reduces blood loss during thoracolumbar spine fusion surgery. Researchers will measure bleeding severity during surgery using a validated scale and compare results with similar past patients who d…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
Proton beam plus chemo: a new hope for pancreatic cancer?
Disease control OngoingThis study is testing a combination of two chemotherapy drugs (gemcitabine and nab-paclitaxel) with a precise type of radiation called proton therapy for people with locally advanced pancreatic cancer that cannot be removed by surgery. The goal is to find the highest safe dose of…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
Laser and radiation combo takes on recurrent brain tumors
Disease control OngoingThis pilot study is testing a two-step treatment for people whose gliomas (a type of brain tumor) have come back after standard therapy. First, doctors use a laser guided by MRI to destroy as much tumor as possible. Then, they give a short course of focused radiation. The main go…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
App aims to keep IBD patients on track
Disease control OngoingThis study tests a digital health system that reminds people with inflammatory bowel disease (IBD) to take their medication and lets them report symptoms. About 123 adults starting a new oral or injectable treatment will use the system or get standard care for 12 months. The goal…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC
-
Can less radiation be safer for throat cancer?
Disease control OngoingThis trial tests whether giving radiation to a smaller area of the neck can prevent throat cancer from returning while reducing side effects. People with p16-positive oropharynx cancer (a type linked to HPV) who are getting radiation therapy may be eligible. The goal is to see if…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
A nose spray before treatment: could naloxone speed up opioid recovery for fentanyl users?
Disease control OngoingThis trial tests whether giving naloxone — the opioid-overdose reversal drug — just before buprenorphine can help people who use fentanyl start addiction treatment more quickly and with less discomfort. The study enrolls a small group of adults with opioid use disorder who test p…
Phase 3 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 29, 2026 00:00 UTC
-
Could a gut supplement boost brain health in schizophrenia?
Disease control OngoingThis study tests whether a prebiotic supplement (Prebiotin®) can reduce inflammation and improve thinking in people with schizophrenia or schizoaffective disorder. Sixty adults aged 18-60 who are stable on antipsychotics will take the prebiotic or a placebo for 12 weeks. Research…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Triple therapy aims to stop muscle loss in older ICU patients
Disease control OngoingThis study tests whether starting physical therapy, electric muscle stimulation, and high-protein supplements early in the ICU can prevent the muscle loss, weakness, and mental decline known as post-intensive care syndrome (PICS). The trial enrolls adults aged 45 and older who ar…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC
-
Experimental combo targets Hard-to-Treat pancreatic cancer
Disease control OngoingThis phase 2 trial tests whether adding galeterone to standard chemotherapy (gemcitabine) can shrink tumors or slow disease in people with advanced pancreatic cancer that has not responded to prior treatments. The study enrolls about 15 adults with metastatic disease who have alr…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Can a smartphone app help end HIV in young gay men?
Disease control By invitation onlyThis study tests a mobile app called HealthMPowerment (HMP) designed to help young gay and bisexual men (ages 15-24) either start HIV prevention (PrEP) or stay on HIV treatment. About 1500 participants will get the app right away or after a delay. Researchers will see if the app …
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
Proton beam boost: could fewer sessions mean better prostate cancer control?
Disease control OngoingThis early-phase trial tests whether giving higher doses of radiation to the prostate in fewer sessions (while also treating pelvic lymph nodes) is safe for men with intermediate- to high-risk prostate cancer. The study enrolls 18 adults and uses proton beam therapy delivered fou…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug cocktail aims to stall returning prostate cancer
Disease control OngoingThis study looks at men whose prostate cancer has come back in a few spots (oligometastatic) and who have certain gene mutations. It compares standard care (hormone therapy plus radiation) against the same treatment plus a 6-month course of two drugs (niraparib and abiraterone wi…
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Can extra doctor visits after birth save Mothers' hearts?
Disease control OngoingThis study tests whether having more frequent checkups with an obstetric provider or a study nurse during the first year after childbirth can help women with high blood pressure or diabetes manage their health better. One hundred women with Medicaid insurance who had these condit…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Experimental STING drug aims to rev up immune system against stubborn leukemia
Disease control PausedThis early-phase trial tests a drug called CRD3874-SI, which activates the STING protein to help the immune system attack cancer cells. It is for adults with acute myeloid leukemia that has come back or not responded to treatment. The main goals are to check safety and find the r…
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
Can a digital hub keep mentally ill patients healthy at home?
Disease control OngoingThis study tests a telehealth system called Medherent for people with serious mental illness living in the community. The system dispenses medication, monitors health data like blood pressure and blood sugar, and allows virtual doctor visits. Researchers will track whether this a…
Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New drug combo aims to reboot immune attack on head and neck cancer
Disease control OngoingThis phase 2 trial tests whether adding bavituximab to pembrolizumab can help people with advanced head and neck cancer whose tumors have stopped responding to standard immunotherapy. The study enrolled 7 participants and measures how many tumors shrink or disappear. The goal is …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New study tests best way to save Kids' decayed baby teeth
Disease control OngoingThis study looks at three different ways to treat deep cavities in children's baby molars without pulling the tooth. The treatments are two types of pulpotomy (removing part of the tooth nerve and placing a material on it) and an indirect pulp cap (leaving some decay and sealing …
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New study aims to help HIV patients in botswana kick the habit
Disease control By invitation onlyThis study tests a program to help people living with HIV in Botswana stop smoking. It combines counseling with a medication called varenicline. The goal is to see if this approach helps them quit and improves their health. The study involves 750 participants who are daily smoker…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
Heart patch could spot silent stroke risk in elderly women
Diagnosis OngoingThis study is testing whether a wearable heart monitor (Zio patch) worn for two weeks can detect undiagnosed atrial fibrillation in women aged 70 and older. Atrial fibrillation is a common heart rhythm problem that raises stroke risk, especially in older women. The goal is to see…
Sponsor: University of Maryland, Baltimore • Aim: Diagnosis
Last updated Jun 27, 2026 08:13 UTC
-
Massive trial tests azithromycin to prevent stillbirths and infant deaths in west africa
Prevention OngoingThis study tests whether giving the antibiotic azithromycin to pregnant women and their babies during routine care can prevent stillbirths and infant deaths in Mali, a country with very high infant mortality. Over 99,000 participants are involved in this large, placebo-controlled…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Aug 09, 2026 00:00 UTC
-
Old drug, new trick: vancomycin may stop c. diff before it starts
Prevention CancelledThis study tests whether taking oral vancomycin alongside other antibiotics can prevent Clostridioides difficile infection (C. diff) in people aged 65 and older. Participants are randomly assigned to receive either vancomycin or standard care. The goal is to see if the drug reduc…
Phase 2/3 • Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jul 31, 2026 00:00 UTC
-
New program aims to boost HIV prevention in black men
Prevention By invitation onlyThis study tests a personalized support program (C4) to help Black men who have sex with men take their HIV prevention medication (PrEP) consistently. About 350 men will either get the program or standard care. The program addresses personal needs like mental health and housing t…
Sponsor: University of Maryland, Baltimore • Aim: Prevention
Last updated Jun 27, 2026 12:28 UTC
-
Can a diabetes and Weight-Loss drug help break cocaine addiction?
Symptom relief OngoingResearchers are testing whether semaglutide, a drug used for diabetes and weight loss, is safe and tolerable in adults with cocaine use disorder. The trial includes 40 people who use cocaine often, some of whom also have HIV. Participants receive weekly injections of semaglutide …
Phase 2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Sep 12, 2026 00:00 UTC
-
New program aims to ease distress for dementia residents in assisted living
Symptom relief OngoingThis study tests a program called FPCI-AL that helps staff in assisted living communities interact more positively with residents who have dementia. Researchers will work with staff for several months to improve care interactions. The goal is to reduce residents' behavioral sympt…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 30, 2026 00:00 UTC
-
Sound waves zapping pain: new hope for facial neuralgia?
Symptom relief OngoingThis early-phase study tests whether MRI-guided focused ultrasound can safely reduce severe facial pain in people with trigeminal neuralgia that hasn't responded to medication. Ten adults aged 21-75 with chronic pain for over 6 months will receive a precise ultrasound treatment t…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jul 22, 2026 00:00 UTC
-
Exercise program aims to boost strength and endurance in kids with sickle cell disease
Symptom relief OngoingThis study is testing whether a moderate exercise program can improve strength, balance, and endurance in children with sickle cell disease. Twenty children ages 6 to 17 will take part in strengthening and endurance exercises. Researchers will measure changes in muscle strength, …
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
Gum chewing could ease colonoscopy prep, study says
Symptom relief OngoingThis study tests whether chewing sugar-free gum during bowel preparation for colonoscopy can reduce discomfort and improve satisfaction. About 100 adults aged 45-75 will chew gum before and after their prep solution. The goal is to see if this simple trick helps more people compl…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Virtual reality may offer Drug-Free pain relief for jaw disorder sufferers
Symptom relief OngoingThis study explores whether immersive virtual reality can help reduce chronic pain in people with temporomandibular disorder (TMD). About 259 participants will experience active VR, a sham VR, or no VR while their pain tolerance is measured. The goal is to understand how VR works…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Time-Restricted eating may fight frailty in prostate cancer patients
Symptom relief OngoingThis study tests whether eating only within a 10-hour window each day can help prevent frailty in people over 55 who are on hormone therapy for prostate cancer. Frailty makes it harder to recover from stress and can lead to loss of independence. The trial will enroll 30 participa…
Phase 1/2 • Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Could a High-Fat, Low-Carb diet ease schizophrenia?
Symptom relief OngoingThis study tests whether a ketogenic diet—low in carbs, high in fat—can reduce symptoms in people with schizophrenia or schizoaffective disorder. Fifty adults will be randomly assigned to either the ketogenic diet or a regular diet for several weeks. Researchers will measure chan…
Sponsor: University of Maryland, Baltimore • Aim: Symptom relief
Last updated Jun 27, 2026 07:57 UTC
-
Artificial blood could save trauma victims when banked blood is scarce
Knowledge-focused OngoingThis study aims to create a whole blood substitute by combining artificial oxygen carriers, plasma, and platelets. Researchers will test these mixtures in the lab using blood from 250 healthy volunteers to see if they can match the performance of real blood. The goal is to have a…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Aug 27, 2026 00:00 UTC
-
Could a simple blood test guard against organ damage in heart surgery?
Knowledge-focused OngoingThis study looks at how red blood cells break down during prolonged heart-lung bypass in cardiac surgery, releasing free hemoglobin into the blood. Researchers will measure these levels and related proteins in adults undergoing complex heart procedures to see if they can predict …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Aug 23, 2026 00:00 UTC
-
How many days does it take to know if spinal cord stimulation works?
Knowledge-focused By invitation onlyThis study asks how long a spinal cord stimulator (SCS) trial should last to accurately predict whether it will relieve chronic pain. People with chronic pain undergoing a standard SCS trial will fill out daily surveys about their pain and function. The goal is to find the shorte…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Aug 06, 2026 00:00 UTC
-
10-Year hepatitis study aims to unlock secrets of liver disease
Knowledge-focused OngoingThis study follows people with chronic hepatitis B or C for up to 10 years to track how the disease changes over time. A smaller group with hepatitis B will receive the drug tenofovir alafenamide for 2 years to see if it reduces liver stiffness. Participants provide blood samples…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Parenting program aims to boost health in latino kids
Knowledge-focused OngoingThis study tests if a special parenting program (Attachment Biobehavioral Catch-Up) can help low-income Latino children have fewer common illnesses, better sleep, and healthier weight. About 260 mothers and their 9-month-old babies will take part. The program focuses on strengthe…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Smartphone exercise app tested for seniors – but study pulled
Knowledge-focused CancelledThis study aimed to see if a personalized exercise app (Gingko Active) could improve physical function in adults aged 45 and older better than a standard exercise booklet. The trial was withdrawn before any participants enrolled, so no results are available. The app was designed …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:00 UTC
-
Can a keto diet improve mental health? new study trains the trainers
Knowledge-focused OngoingThis study teaches clinicians and researchers how to start and follow a medical ketogenic diet to improve mental health. Participants first attend a mastery class, then optionally try the diet themselves for 4 weeks with group support. The goal is to help professionals feel confi…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:10 UTC
-
Could a painkiller help treat alcoholism? scientists investigate
Knowledge-focused OngoingThis study looks at whether a single dose of diclofenac, a common pain reliever, can change a specific brain chemical in people with alcohol use disorder. Twelve adults with mild to severe alcohol use disorder will receive either diclofenac or a placebo in a double-blind fashion.…
Early phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
New flange fitting method could help NICU moms pump more milk
Knowledge-focused CancelledThis study was designed to see if a new method for fitting breast pump flanges (the part that goes over the breast) helps parents of babies in the NICU produce more milk and feel more satisfied with pumping. Researchers planned to compare the new fitting method to standard instru…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 11:03 UTC
-
Could a pill boost performance in extreme cold and thin air?
Knowledge-focused OngoingThis study tests whether a drug can help red blood cells work better in low-oxygen (hypoxia) and cold (hypothermia) conditions, which are common in high-altitude or military environments. Researchers will measure how the drug affects red blood cell energy and antioxidant defenses…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Hip fracture surgery showdown: replacement vs. fixation under study
Knowledge-focused OngoingThis study looks at two common surgeries for a certain type of hip fracture in people aged 60 and older: hip replacement or using screws/pins to hold the bone together. The main goal is to see if a larger study is possible by checking how many people join, how well the treatments…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:04 UTC
-
Joint infection study pulled before starting: antibiotic duration question remains unanswered
Knowledge-focused CancelledThis study aimed to find the best length of time for patients to take antibiotics after surgery for an infected joint replacement. It planned to compare different antibiotic durations to see which works best to prevent the infection from coming back and to avoid antibiotic resist…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Which invisalign bump works best? new study aims to find out
Knowledge-focused By invitation onlyThis study looks at the small tooth-colored bumps (attachments) used with Invisalign aligners to help move teeth. Researchers want to see which design—optimized or conventional—is placed more accurately and holds its shape longer. Thirty adults starting Invisalign treatment will …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
Walk now or wait? new study tests early weightbearing after fracture surgery
Knowledge-focused By invitation onlyThis study looks at whether patients with surgically treated leg, pelvis, or hip socket fractures can safely start walking right away instead of waiting 6-12 weeks. About 100 adults will be randomly assigned to immediate weightbearing or delayed weightbearing. The goal is to see …
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:15 UTC
-
Can a Mother's active lifestyle shape her Baby's lifelong health?
Knowledge-focused By invitation onlyThis observational study at the University of Maryland will follow 40 pregnant women to see how their physical activity levels influence the development and function of the placenta. Participants will provide biological samples and health information during pregnancy and at deliv…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:12 UTC
-
Typhoid vaccine study probes gut immunity secrets
Knowledge-focused OngoingThis study looks at how the typhoid vaccine changes the immune system and bacteria in the gut. About 87 healthy adults getting a routine colonoscopy will either receive the vaccine before the procedure, after, or not at all. Researchers will analyze blood, tissue, and stool sampl…
Phase 4 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:08 UTC
-
Amish volunteers help unlock genetic secrets of diabetes drug
Knowledge-focused OngoingThis study looks at whether a person's genes can predict how their body responds to canagliflozin, a drug used for type 2 diabetes. About 700 healthy Amish adults will take the drug for five days, and researchers will measure changes in urine sugar and other markers. The goal is …
Phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:05 UTC
-
Study to find fastest way to start IVs in hard-to-stick patients
Knowledge-focused CancelledThis study aimed to compare two devices—ultrasound and a near-infrared device called Vein Viewer—to see which helps emergency room staff start IVs faster in patients with difficult veins. The goal was to reduce delays in care. However, the study was withdrawn before enrolling any…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Study on GLP-1 for type 1 diabetes withdrawn before it began
Knowledge-focused CancelledThis early-stage study planned to test whether a drug called glucagon-like peptide-1 (GLP-1) could protect blood vessels from damage caused by repeated low blood sugar in people with type 1 diabetes. The researchers aimed to enroll 40 adults aged 18–50. However, the study was wit…
Early phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC
-
Old stroke data gets a modern check: do newer drugs lower risk?
Knowledge-focused OngoingThis study looks at whether modern medicines (like statins and newer blood thinners) can keep the one-year stroke rate below 5% in people with narrowed neck arteries who have already had a minor stroke or warning signs. About 114 participants are being followed to see how well th…
Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
Could a gut hormone protect your blood vessels during low blood sugar?
Knowledge-focused OngoingThis study looks at how low blood sugar (hypoglycemia) affects blood vessel function in people with type 2 diabetes and healthy adults. Researchers want to learn if a natural gut hormone called GLP-1 can change these effects. The study involves 28 participants and measures change…
Early phase 1 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:53 UTC